JNCE

Jounce Therapeutics, Inc. JNCE

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JNCE HLVX AADI MIRO IMDX CYT OPNT RVLP BLI TRML
6M 109.45 % 23.67 % -4.65 % 78.42 % 83.85 % -1.63 % 92.09 % -96.93 % -40.59 % 185.80 %
YTD 72.48 % 0.48 % -34.71 % 0.00 % 127.25 % 0.00 % 2.03 % -97.55 % -55.39 % 132.07 %
1Y -49.19 % 11.76 % 12.64 % 5.33 % 69.71 % 55.68 % -3.59 % -98.08 % -78.87 % 69.20 %
3Y -65.94 % -87.39 % -86.82 % -77.76 % -65.62 % -82.64 % 115.55 % -99.54 % -98.17 % 97.93 %
5Y -74.83 % -89.05 % -76.30 % -77.76 % -82.47 % -82.64 % 8.68 % -99.60 % -98.17 % -70.52 %
10Y -89.10 % -89.05 % -97.72 % -77.76 % -96.72 % -82.64 % 41 200.00 % -99.65 % -98.17 % -70.52 %
From the beginning -89.10 % -89.05 % -97.72 % -77.76 % -96.72 % -82.64 % -63.55 % -99.65 % -98.17 % -70.52 %

Dividend

Cyteir Therapeutics, Inc.

Tourmaline Bio, Inc.